948 results on '"Klauschen, Frederick"'
Search Results
202. Multiclass cancer classification in fresh frozen and formalin-fixed paraffin-embedded tissue by DigiWest multiplex protein analysis
203. Hidden Variables in Deep Learning Digital Pathology and Their Potential to Cause Batch Effects: Prediction Model Study (Preprint)
204. High‐protein diet more effectively reduces hepatic fat than low‐protein diet despite lower autophagy and FGF21 levels
205. TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial
206. Distinct immune evasion in APOBEC ‐enriched, HPV ‐negative HNSCC
207. Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer
208. Association of a STK11/KEAP1-mutation gene expression signature in lung adenocarcinoma with immune desertion in squamous cell carcinomas and mediation by NFE2L2 deregulation.
209. Resolving challenges in deep learning-based analyses of histopathological images using explanation methods
210. Support of a molecular tumour board by an evidence-based decision management system for precision oncology
211. Human Lungs Show Limited Permissiveness for SARS-CoV-2 Due to Scarce ACE2 Levels But Strong Virus-Induced Immune Activation in Alveolar Macrophages
212. Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options
213. Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy
214. Evaluation of automated brain MR image segmentation and volumetry methods
215. Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location‐dependent patterns of genetic and epigenetic alterations.
216. MOESM1 of Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy
217. Clinical relevance of comprehensive genomic analysis in advanced-stage cancers and rare malignancies : Results from the MASTER trial of the German Cancer Consortium
218. DNA Methylation Profiling of Salivary Gland Tumors Supports and Expands Conventional Classification
219. Correction: Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation
220. Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation
221. Tissue clonality of dendritic cell subsets and emergency DCpoiesis revealed by multicolor fate mapping of DC progenitors
222. Resolving challenges in deep learning-based analyses of histopathological images using explanation methods
223. DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status.
224. Segmentation-dependent brain volume estimation using simulated MRI data: WE 363
225. Comprehensive micro-scaled proteome and phosphoproteome characterization of archived retrospective cancer repositories.
226. Histologische, immunhistologische und molekularpathologische Aspekte bei nichtmelanozytären Hauttumoren: Praktische Hinweise zur Anwendung der deutschen Leitlinien.
227. Forget lung, breast or prostate cancer? Why we shouldn’t abandon tumour names yet.
228. Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue – a GC-TOFMS based metabolomics study
229. Rare digital Pacinian corpuscle neuroma: case report and review of the literature
230. Towards computational fluorescence microscopy: Machine learning-based integrated prediction of morphological and molecular tumor profiles
231. Additional file 1: of Computational analysis reveals histotype-dependent molecular profile and actionable mutation effects across cancers
232. Epidermal gamma delta T cells originate from yolk sac hematopoiesis and clonally self-renew in the adult
233. PATH-53. IMMUNOLOGICAL PROFILING OF MUTATIONAL AND TRANSCRIPTIONAL SUBGROUPS IN PEDIATRIC AND ADULT HIGH-GRADE GLIOMAS
234. Genomanalyse maligner Tumoren
235. Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases
236. Histomorphological and molecular profiling: friends not foes! Morpho‐molecular analysis reveals agreement between histological and molecular profiling
237. Clinical Impact of Rare and Compound Mutations of Epidermal Growth Factor Receptor in Patients With Non–Small-Cell Lung Cancer
238. Immunologic Profiling of Mutational and Transcriptional Subgroups in Pediatric and Adult High-Grade Gliomas
239. Immunohistochemical analysis of Bcl‐2, nuclear S100A4, MITF and Ki67 for risk stratification of early‐stage melanoma – A combined IHC score for melanoma risk stratification
240. Immunhistochemische Analyse von Bcl‐2, nukleärem S100A4, MITF und Ki67 zur Risikostratifizierung von Melanomen im Frühstadium – ein kombinierter immunhistochemischer Score
241. Abstract 468: Clinical relevance of comprehensive genomic analysis in advanced-stage cancers and rare malignancies: Results from the MASTER trial of the German Cancer Consortium
242. Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial
243. Regulatory T cells differ from conventional CD 4 + T cells in their recirculatory behavior and lymph node transit times
244. DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer
245. Variant classification in precision oncology
246. Precision oncology for the treatment of salivary gland tumors.
247. Clinical impact of comprehensive versus targeted genomic analysis for precision oncology.
248. Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII + IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trial
249. Somatic genome alterations in relation to age in lung adenocarcinoma
250. Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.